Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mereo Biopharma Group Plc ADR
(NQ:
MREO
)
2.740
-0.070 (-2.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
562,550
Open
2.810
Bid (Size)
2.630 (1)
Ask (Size)
3.000 (1)
Prev. Close
2.810
Today's Range
2.730 - 2.810
52wk Range
0.9201 - 4.360
Shares Outstanding
584,908,239
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 22, 2024
Via
Benzinga
Performance
YTD
+19.13%
+19.13%
1 Month
-8.67%
-8.67%
3 Month
-30.10%
-30.10%
6 Month
+51.38%
+51.38%
1 Year
+128.33%
+128.33%
More News
Read More
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
March 27, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
MicroMarvel: Mereo BioPharma - Analysts Favorite
January 16, 2024
Via
Talk Markets
Why Ultragenyx Pharma Stock Is Trading Higher Premarket Today
June 06, 2023
Via
Benzinga
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
March 05, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 26, 2024
Via
Benzinga
Booz Allen Hamilton Posts Upbeat Results, Joins AppFolio, Gentex And Other Big Stocks Moving Higher On Friday
January 26, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
January 08, 2024
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
October 23, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Why Is Mereo BioPharma Stock Trading Higher Today?
October 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 16, 2023
Via
Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 16, 2023
Via
InvestorPlace
Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)
October 14, 2023
From
Ultragenyx Pharmaceutical Inc.; Mereo Biopharma
Via
GlobeNewswire
Ultragenyx to Present Setrusumab (UX143) Update at ASBMR 2023 Including New Data from Phase 2/3 Orbit Study in Osteogenesis Imperfecta (OI)
October 09, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
GlobeNewswire
Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
September 21, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update
September 07, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Ultragenyx Announces First Patients Dosed in Phase 3 Program Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
July 06, 2023
From
Ultragenyx Pharmaceutical Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 07, 2023
Via
Benzinga
Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
June 06, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 06, 2023
Via
InvestorPlace
Mereo BioPharma to Present at the Jefferies Healthcare Conference
May 31, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Phase 2 Data from “ASTRAEUS” Trial of Mereo BioPharma’s Alvelestat in Alpha-1 Antitrypsin Deficiency-associated Lung Disease Presented at the 2023 American Thoracic Society International Conference
May 23, 2023
From
Mereo BioPharma Group plc
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.